It's Time for Hospitals to Put Patients First


By Sally C. Pipes


Many hospitals are refusing to comply with a Trump-era requirement that went into effect on January 1st of this year to publish the prices for more than 300 "shoppable" medical procedures.


This intransigence is alarming -- and expensive. The rule could save American patients and insurers up to $27 billion annually, but only if hospitals play ball.


Rates of noncompliance are extraordinarily high. Three-quarters of the highest-earning hospitals in the country aren't fully compliant with the rule, according to researchers at Harvard Medical School. A March analysis found that two-thirds of hospitals weren't complying.


When hospitals don't publish their prices, patients have no way of knowing if they're getting a good deal on elective surgeries and other procedures -- or getting ripped off.


Prices for identical services vary widely, depending on the location and provider. Even in the same city, there are major price discrepancies. The most expensive 5% of hospitals in metro areas containing over 3 million people receive almost $1,400 for each knee MRI, on average. The least expensive 5% of hospitals in those metro areas take in just $600 for the scan, according to Crowe, a consulting firm.


If a gas station or grocery store tried to slap a 133% premium on an identical product, they wouldn't get much business. Customers shopping for gas or food can easily compare prices and find a more competitive option.


That's why hospitals are so loathe to comply with the rule -- the lack of transparency makes it much easier to gouge patients and insurers.


Hospital groups have already lost two court challenges against the rule. Their attorneys claimed that patients would be unable to decipher byzantine pricing schedules and could not be trusted to make responsible financial and health decisions. They complained that publishing their prices would be an expensive regulatory burden.


But consumers make weighty financial and health decisions all the time. Transparent prices make that task easier, not harder.


Perhaps the best example is Lasik eye surgery. Because the procedure is optional, many insurers don't cover it. Patients must pay out of pocket. That incentivizes them to shop around and compare different providers.


It's no coincidence that Lasik has gotten cheaper since the turn of the century in inflation-adjusted dollars, while virtually every other hospital procedure has gotten dramatically more expensive.


The notion that publishing prices is some gargantuan regulatory burden is ridiculous. The Centers for Medicare and Medicaid Services estimates that the direct cost to hospitals in the first year would be around $12,000 -- far less than a single administrative worker's full-time salary, and a drop in the bucket for hospitals that bring in tens of millions of dollars each year.


The fight to make health care more affordable and accessible for ordinary Americans begins with price transparency. It's long past time for hospitals to publish their prices -- so that market competition can drive down costs and improve quality.


Sally C. Pipes is President, CEO, and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute. Her latest book is False Premise, False Promise: The Disastrous Reality of Medicare for All (Encounter 2020). Follow her on Twitter @sallypipes.

More Resources


04/27/2024
With Trump in Court, Can Biden Take Advantage?
As polls show the race tied, the president is campaigning around the country and his opponent is stuck spending his days in a Manhattan courtroom

more info


04/27/2024
Biden's Outrageous Quest To Jail Trump Before the Election
The Manhattan hush-money case is absurd, unjust and outrageously partisan.

more info


04/27/2024
Navigating Transitions in an Uncertain Economy
Mohamed ElErian explains how to recalibrate expectations in the face of yet another forecasting failure

more info


04/27/2024
PA Could Be 'Ground Zero' for a Novel Presidential Tie
Pennsylvania is the top battleground state that President Joe Biden needs to win to stave off a 2024 loss to Donald Trump or an electoral tie.

more info


04/27/2024
The Most Feared and Least Known Political Operative in U.S.
Susie Wiles, the people who know her the best believe, is a force more sensed than seen. Her influence on political events, to many who know what they're watching, is as obvious as it is invisible. The prints leave not so much as a smudge. It's a shock when she shows up in pictures. Even then it is almost always in the background. She speaks on the record hardly ever, and she speaks about herself even less.

more info


04/27/2024
All the Disinformation That's Fit To Print
Will heavy-handed U.S. intelligence spooks re-elect Trump? Will the New York Times help?

more info


04/27/2024
Arizona Indictments Come at the Worst Time for Trump
The Supreme Court should focus on the crimes Donald Trump's allies are accused of committing when it rules on the

more info


04/27/2024
SCOTUS Hears Trump's Immunity Claim


more info


04/27/2024
Biden's Civil Rights Rollback
Under Trump, college kids accused of sexual assault were given the right to defend themselves. With his update of Title IX, Biden has taken it away.

more info


04/27/2024
House Speaker Mike Jellyfish Flops Again
House Speaker Mike Johnson has gone from zero to Mitch McConnell in record time. The conservative firebrand who was elected last Oct. 25 to lead Republicans to greater glory now resembles his depleted Senate counterpart.

more info


04/27/2024
Ukraine Is Far From Doomed
When comparing Ukraine's situation in 2024 to Europe's in 1941, Russia's defeat seems entirely possible.

more info


04/27/2024
How a Nation Reformed Its Universities
Universities are once again at the center of national debate.

more info


04/27/2024
Why the Israel-Hamas War Has Spun Campuses Into Chaos


more info


04/27/2024
No One Has a Right To Protest at My Home


more info


04/27/2024
The Real Reagan: Getting Beyond the Caricatures


more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."